# Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

> **NCT03871621** · PHASE4 · COMPLETED · sponsor: **Mackay Memorial Hospital** · enrollment: 76 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Diabetes Medicines
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT03871621
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-08-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03871621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03871621, "Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03871621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*